Perfil
Peder Møller Andersen currently works at Biosergen AB, as Chief Medical Officer from 2024.
Dr. Andersen also formerly worked at Biosergen AS, as Chief Executive Officer & Director, Forward Pharma GmbH, as Managing Director from 2009 to 2016, Astion Pharma A, as Vice President-Clinical Development from 2010 to 2012, and Forward Pharma A, as Chief Operating Officer in 2017.
Dr. Andersen received his doctorate degree in 1981 from the University of Copenhagen.
Cargos activos de Peder Andersen
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOSERGEN AB | Director Técnico/Científico/I+D | 31/01/2024 |
Antiguos cargos conocidos de Peder Andersen.
| Empresas | Cargo | Fin |
|---|---|---|
| FORWARD PHARMA A/S | Director Ejecutivo | 01/03/2017 |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Director Ejecutivo | 01/01/2016 |
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director Técnico/Científico/I+D | 01/01/2012 |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Director Ejecutivo | - |
Formación de Peder Andersen.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Biosergen AB
Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
- Bolsa de valores
- Insiders
- Peder Andersen
















